Multiple Biomarker Use for Detection of Adverse Events in ... - CiteSeerX
Recommend Documents
Abstract: Older hospitalized patients are at risk of experiencing adverse events including, but ..... approved by the Capital District Health Authority Research.
Mar 5, 2013 - well-established single-biomarker methods are comparable after proper realignment of .... single-biomarker measurements, in a large ongoing cohort study of ... dyslipidemia, elevated blood pressure and fasting plasma glucose, ... hours)
Nov 8, 2013 - linearly constrained quadratic programming problem so that the solution of .... Database (IPAD) (http://bioinfo.hsc.unt.edu/ipad/) [17] is used for ...
Los resultados evidenciaron que los curativos influenciaron los motivos de retirada del ... Estudo randomizado e controlado que objetivou identificar motivos de ...
... The Thai Anesthesia. Incidents Study (THAI Study) Database of 25,098 Cases .... were the basic monitoring tools used during anesthesia in most operations.
3Department of Computer Science, QMW, University of London, London E1 4NS ... use of computers to support the application of cancer protocols and ignores.
Logical reasoning about safety issues is an ... the majority of cancer therapy in the outpatient setting is .... The protocol-based treatment suggestions computed.
Aims: Continuous glucose monitoring (CGM) using transcutaneous sensors is becoming a ..... K, Bartek J, HuÄÃková J. DegifXL â a new software program for de-.
comparison correction of thousands of genes. After meta-analysis by ..... biomarkers from HSB may only help identify technical issues across the ..... (IPA) software to investigate which biological functions are .... bench to the computer desk.
hiccups, dizziness, high blood pressure, asthenia, fatigue, worsen of spasticity, respiratory infection, urinary infection, visual blurring, low fever and paresthesia ...
Key words: multiple sclerosis, natalizumab, adverse events, antibodies, monoclonal. RESUMO .... izumab treatment, although four patients presented more.
Jan 17, 2013 - and Infectious Diseases, National Institutes of Health and Harriet L. .... Bart PA, Goodall R, Barber T, Harari A, Guimaraes-Walker A, et al. (2008).
Reprint Requests: Dr. Bryce Larke, Yukon Medical Health Officer, 4 Hospital Road, Whitehorse, YT. Y1A 3H8, Tel: 867-667-5716, Fax: 867-667-8349, E-mail: ...
project framework, is to use data mining (e.g., decision trees) to electronically ... Keywords. data mining, medical informatics, adverse drug events, decision trees,.
Nov 13, 2016 - Conclusions: Ezetimibe use has increased rapidly in Australia since receiving ..... Melbourne: National Heart Foundation of Australia; 2014. 7.
Sep 9, 2013 - INTRODUCTION. Suspected adverse reactions following immunisation with marketed vaccines are reported to a spontane- ous report system ...
manuscripts and patents published on the synthesis and potential activity of these ...... amino-nitrazepam, nitrazepam and ethanol. (184). 40 y/o M taken to ED ...
Mar 5, 2013 - Multiple Inflammatory Biomarker Detection in a. Prospective Cohort Study: A Cross-Validation between. Well-Established Single-Biomarker ...
thrax spores distributed in ihe mail led to 12 confirmed or suspected cases of ... licensed by the Food and Ding Ad- ministration (FDA) in 1970. was de- termined ...
May 14, 2014 - taxanes $1,142, capecitabine $1,817; SL incremental cost: taxanes $1,448, ... Conclusions: Adverse events in taxane- or capecitabine-treated ...
Aug 20, 2014 - Funding: John W. Jackson was supported by NIMH Training Grant in Training in Psychiatric Genetics and Translational Research (T32 ...
Results: The computer monitoring strategy identified 2,620 alerts, of which 275 were determined ...... based monitors are probably the most practical tools.
lysis syndrome occurs, therapy should be interrupted until symptoms resolve. .... (8086) and poster presented at the Annual Meeting of the American. Society of ...
Multiple Biomarker Use for Detection of Adverse Events in ... - CiteSeerX
FRED S. ApplE,1* LEslY A. PEARcE,2 ADRiNE CHuNG,1 RANKA LER,1 and. MARYANN M. MuRAKAMi1 ... 2 Biostatistical Consulting, Minot, ND. * Address ...
Clinical Chemistry 53:5 874 – 881 (2007)
Proteomics and Protein Markers
Multiple Biomarker Use for Detection of Adverse Events in Patients Presenting with Symptoms Suggestive of Acute Coronary Syndrome Fred S. Apple,1* Lesly A. Pearce,2 Adrine Chung,1 Ranka Ler,1 and MaryAnn M. Murakami1
predictive of mortality, and PlGF (RR 2.0, P ⴝ 0.08) approached significance. Patients with increased NTproBNP (12.3%) or cTnI (33.8%) had higher cardiac event rates (each P
